Edwards Lifesciences Corporation
EWCompany Overview
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Country
US
Market Cap
$44.97B
Last Fiscal Year
2023
Final Shariah Status
Passed
Compliance Analysis Overview
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
0.73%
passed
Liabilities Compliance
1.55%
passed
Final Shariah Status
Passed
This stock meets all Shariah compliance criteria according to AAOIFI standards.
Stock Information
Name | Edwards Lifesciences Corporation |
Ticker | EW |
Main Business | Medical Devices |
Type | Common Stock |
Industry | Medical Devices |
Country | US |
Market Cap | $44.97 B |
Shariah Analysis Breakdown
Business compliance Breakdown
Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
---|---|---|---|
Transcatheter Aortic Valve Replacement | $3,518.2 | $0.0 | - |
Transcatheter Mitral and Tricuspid Therapies | $116.1 | $0.0 | - |
Surgical Heart Valve Therapy | $893.1 | $0.0 | - |
Critical Care | $855.0 | $0.0 | - |
Interest income | $35.5 | $35.5 | - |
Other income | $2.6 | $3.8 | Gain on insurance settlement |
Total | $5,420.5 | $39.3 | 0.73% (passed) |
Liabilities Compliance Breakdown
Liability Item | Value ($M) | % of Market Cap |
---|---|---|
current debt and capital lease obligation | $24,900,000.0 | 0.06% |
long term debt and capital lease obligation | $670,000,000.0 | 1.49% |
Total Interest-Bearing Debt | $694,900,000.0 | 1.55% |
Market Capitalization | $44,972,250,000.0 | 100.00% |
Compliance Status | Threshold: 33% | passed |